{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:07:24Z","timestamp":1780477644462,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.adro.2021.100748","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T01:38:46Z","timestamp":1625103526000},"page":"100748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Magnetic Resonance\u2013Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry Study"],"prefix":"10.1016","volume":"6","author":[{"given":"Morgan","family":"Michalet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Riou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Valdenaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Debuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Ailleres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Draghici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Charissoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Llacer","family":"Moscardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Farcy-Jacquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Fenoglietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7533-2988","authenticated-orcid":false,"given":"David","family":"Azria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2021.100748_bib0001","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2021.100748_bib0002","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2021.100748_bib0003","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncr.23161","article-title":"Treatment failure after primary and salvage therapy for prostate cancer","volume":"112","author":"Agarwal","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2021.100748_bib0004","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.purol.2015.06.003","article-title":"Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET\/CT in the assessment of local recurrence","volume":"25","author":"Brenot-Rossi","year":"2015","journal-title":"Prog Urol"},{"key":"10.1016\/j.adro.2021.100748_bib0005","first-page":"474","article-title":"PET\/CT and biochemical recurrence of prostate adenocarcinoma: Added value of 68Ga-PSMA-11 when 18F-fluorocholine is non-contributive","volume":"27","author":"Gauthe","year":"2017","journal-title":"Prog Urol"},{"key":"10.1016\/j.adro.2021.100748_bib0006","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.canrad.2014.07.148","article-title":"Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment","volume":"18","author":"Cochet","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.adro.2021.100748_bib0007","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1470-2045(16)00107-8","article-title":"Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): A randomised, multicentre, non-blinded, phase 3 trial","volume":"17","author":"Duchesne","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2021.100748_bib0008","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1464-410X.2012.11774.x","article-title":"Androgen deprivation therapy: Evidence-based management of side effects","volume":"111","author":"Ahmadi","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.adro.2021.100748_bib0009","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.eururo.2012.01.022","article-title":"Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: A systematic review of the literature","volume":"61","author":"Chade","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2021.100748_bib0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2010.12.012","article-title":"Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer","volume":"60","author":"Williams","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2021.100748_bib0011","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/bju.13766","article-title":"Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients","volume":"119","author":"Crouzet","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.adro.2021.100748_bib0012","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.canrad.2019.07.125","article-title":"Salvage reirradiation for local prostate cancer recurrence after radiation therapy. For who? When? How?","volume":"23","author":"Baty","year":"2019","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.adro.2021.100748_bib0013","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.semradonc.2014.02.008","article-title":"The ViewRay system: Magnetic resonance-guided and controlled radiotherapy","volume":"24","author":"Mutic","year":"2014","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.adro.2021.100748_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026666","article-title":"GETUG-AFU 31: A phase I\/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy-study protocol","volume":"9","author":"Pasquier","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.adro.2021.100748_bib0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clon.2017.11.007","article-title":"Robotic stereotactic retreatment for biochemical control in previously irradiated patients affected by recurrent prostate cancer","volume":"30","author":"Loi","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.adro.2021.100748_bib0016","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13014-017-0833-9","article-title":"Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: Preliminary results of the Oscar Lambret Center","volume":"12","author":"Leroy","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2021.100748_bib0017","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180494","article-title":"Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT)","volume":"92","author":"Jereczek-Fossa","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.adro.2021.100748_bib0018","first-page":"105","article-title":"HDR brachytherapy as a solution in recurrences of locally advanced prostate cancer","volume":"1","author":"\u0141yczek","year":"2009","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.adro.2021.100748_bib0019","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijrobp.2013.01.027","article-title":"Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes","volume":"86","author":"Chen","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2021.100748_bib0020","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1177\/1533034617741797","article-title":"Focal MRI-guided salvage high-dose-rate brachytherapy in patients with radiorecurrent prostate cancer","volume":"16","author":"Maenhout","year":"2017","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.adro.2021.100748_bib0021","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijrobp.2018.06.039","article-title":"Focal salvage high dose-rate brachytherapy for locally recurrent prostate cancer after primary radiation therapy failure: Results from a prospective clinical trial","volume":"102","author":"Murgic","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2021.100748_bib0022","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00066-013-0486-z","article-title":"Salvage prostate HDR brachytherapy combined with interstitial hyperthermia for local recurrence after radiation therapy failure","volume":"190","author":"Kukie\u0142ka","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2021.100748_bib0023","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/pros.2990230403","article-title":"Use of percutaneous transperineal 198-Au seeds to treat recurrent prostate adenocarcinoma after failure of definitive radiotherapy","volume":"23","author":"Loening","year":"1993","journal-title":"Prostate"},{"key":"10.1016\/j.adro.2021.100748_bib0024","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0090-4295(98)00492-0","article-title":"Salvage brachytherapy for localized prostate cancer after radiotherapy failure","volume":"53","author":"Grado","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.adro.2021.100748_bib0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brachy.2009.06.007","article-title":"Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapy","volume":"9","author":"Moman","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2021.100748_bib0026","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijrobp.2019.10.014","article-title":"Retreatment for local recurrence of prostatic carcinoma after prior therapeutic irradiation: Efficacy and toxicity of HDR-Like SBRT","volume":"106","author":"Fuller","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2021.100748_bib0027","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijrobp.2015.10.015","article-title":"Online magnetic resonance image guided adaptive radiation therapy: First clinical applications","volume":"94","author":"Acharya","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.adro.2021.100748_bib0028","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijrobp.2020.02.025","article-title":"Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors","volume":"107","author":"Finazzi","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.adro.2021.100748_bib0029","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.adro.2017.05.006","article-title":"Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system","volume":"2","author":"Fischer-Valuck","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2021.100748_bib0030","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1016\/j.prro.2015.04.009","article-title":"High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment","volume":"5","author":"Fuller","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2021.100748_bib0031","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13014-017-0789-9","article-title":"Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy","volume":"12","author":"Mbeutcha","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2021.100748_bib0032","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818785496","article-title":"Salvage cyberKnife-based reirradiation of patients with recurrent prostate cancer: The single-center experience","volume":"17","author":"Miszczyk","year":"2018","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.adro.2021.100748_bib0033","article-title":"A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER) [e-pub ahead of print]","author":"Valle","year":"2020","journal-title":"Eur Urol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109421001068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109421001068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:38:40Z","timestamp":1762529920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109421001068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2452109421001068"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2021.100748","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnetic Resonance\u2013Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry Study","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2021.100748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100748"}}